TransMedics

TMDX NASDAQ
Overview Stats Financials News

Quarterly Financials

Values in thousands 2024-03-31 2023-12-31 2023-09-30 2023-06-30
Revenue $96,850 $81,174 $66,430 $52,465
Gross Profit 59,862 47,924 40,662 36,741
EBITDA 16,823 6,308 -23,339 1,525
EBIT 12,421 2,603 -28,335 -906
Net Income 12,197 4,031 -25,422 -1,001
Net Change In Cash 96,850 81,174 66,430 52,465
Free Cash Flow -47,607 -33,514 -141,802 -7,183
Cash 350,217 394,812 427,110 582,210
Basic Shares 34,678 34,179 32,614 32,545

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue $241,623 $93,459 $30,262 $25,639
Gross Profit 153,993 65,272 21,159 16,635
EBITDA 8,762 -32,439 -40,305 -24,731
EBIT 485 -31,437 -39,428 -26,384
Net Income -25,028 -36,231 -44,215 -28,748
Net Change In Cash 241,623 93,459 30,262 25,639
Cost of Revenue 1,796
Free Cash Flow -192,087 -57,724 -32,383 -30,720
Cash 394,812 201,182 25,580 24,581
Basic Shares 32,517 29,556 27,616 24,702

Earnings Calls

Quarter EPS
2024-03-31 $0.35
2023-12-31 $0.12
2023-09-30 -$0.78
2023-06-30 -$0.03